Focusing the Controversies in Budd-Chiari Syndrome Management

Andrea       Mancuso
doi:10.2174/2666290601666210406162525
Abstract

Budd-Chiari Syndrome (BCS) is characterized by significant clinical and pathophysiological aspects that seem to allow a sharp differentiation between a variant in the West from one in the East.
The aim of this paper is to focus on the main issues and controversies about the management of BCS in the West. The study discusses different treatment options and how research is trying to solve controversies about debated topics, such as the timing of treatment. In fact, guidelines regarding management of BCS suggest a step-wise strategy starting with medical therapy, arriving at revascularization or TIPS as the second step, and culminating to liver transplant as rescue therapy.
However, long-term outcome is frequently dismal on sole medical therapy. In fact, it is a matter of debate whether further intervention should be suggested only when hemodynamic consequences of portal hypertension are evident. However, as recently hypothesized, chronic micro-vascular ischemia due to impaired venous hepatic outflow could trigger liver fibrosis, resulting in portal hypertension and progressive liver failure. Consequently, liver congestion relief through treatment might be useful as a preventive tool. Recently, early TIPS proved to improve BCS outcome. A direct comparison of early intervention versus step-wise strategy would seem advisable. Furthermore, further studies should address whether non-invasive tools could predict which patients benefit from early intervention.
Keywords: Budd-Chiari syndrome, TIPS, liver transplant, outcome, hepatocellular carcinoma, diagnosis.
[1]
Mancuso, A. Timing of TIPS in Budd Chiari syndrome: an Italian Hepatologist’s perspective. J. Transl. Int. Med.,  2017, 5(4), 194-199.
 [http://dx.doi.org/10.1515/jtim-2017-0033] [PMID: 29340275]

[2]
DeLeve, L.D.; Valla, D.C.; Garcia-Tsao, G. American association for the study liver diseases. Vascular Disorders Of The Liver. Hepatology,  2009, 49(5), 1729-1764.
 [http://dx.doi.org/10.1002/hep.22772] [PMID: 19399912]

[3]
Mancuso, A. Budd-Chiari syndrome management: Lights and shadows. World J. Hepatol.,  2011, 3(10), 262-264.
 [http://dx.doi.org/10.4254/wjh.v3.i10.262] [PMID: 22059108]

[4]
Mancuso, A. An update on management of Budd-Chiari syndrome. Ann. Hepatol.,  2014, 13(3), 323-326.
 [http://dx.doi.org/10.1016/S1665-2681(19)30860-9] [PMID: 24756006]

[5]
Garcia-Pagán, J.C.; Buscarini, E.; Janssen, H.L.A. European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. EASL clinical practice guidelines: vascular diseases of the liver. J. Hepatol.,  2016, 64(1), 179-202.
 [http://dx.doi.org/10.1016/j.jhep.2015.07.040] [PMID: 26516032]

[6]
Qi, X.; Han, G.; Guo, X.; De Stefano, V.; Xu, K.; Lu, Z.; Xu, H.; Mancuso, A.; Zhang, W.; Han, X.; Valla, D.C.; Fan, D. Review article: the aetiology of primary Budd-Chiari syndrome - differences between the West and China. Aliment. Pharmacol. Ther.,  2016, 44(11-12), 1152-1167.
 [http://dx.doi.org/10.1111/apt.13815] [PMID: 27734511]

[7]
Mancuso, A. Budd-chiari syndrome in the West and the East: Same syndrome, different diseases. Liver Int.,  2019, 39(12), 2417-2419.
 [http://dx.doi.org/10.1111/liv.14131] [PMID: 31066181]

[8]
Bargalló, X.; Gilabert, R.; Nicolau, C.; García-Pagán, J.C.; Ayuso, J.R.; Brú, C. Sonography of Budd-chiari syndrome. AJR Am. J. Roentgenol.,  2006, 187(1)W33-41
 [http://dx.doi.org/10.2214/AJR.04.0918] [PMID: 16794137]

[9]
Van, Wettere Imaging in Budd–Chiari syndrome. In: Budd-Chiari Syndrome,  Xingshun, Qi, Ed.; Springer Nature: Singapore, 2020; pp. 39-55.

[10]
Gupta, P.; Bansal, V.; Kumar-M, P.; Sinha, S.K.; Samanta, J.; Mandavdhare, H.; Sharma, V.; Dutta, U.; Kochhar, R. Diagnostic accuracy of Doppler ultrasound, CT and MRI in Budd Chiari syndrome: systematic review and meta-analysis. Br. J. Radiol.,  2020, 93(1109)20190847
 [http://dx.doi.org/10.1259/bjr.20190847] [PMID: 32150462]

[11]
Mancuso, A.; Butera, G.; Politi, F.; Maringhini, A. Budd Chiari syndrome presenting with hepatic transient mosaic enhancement pattern and treated with early TIPS. AME Med. J.,  2017, 2, 60.
 [http://dx.doi.org/10.21037/amj.2017.05.12]

[12]
Ronot, M.; Kerbaol, A.; Rautou, P.E.; Brancatelli, G.; Bedossa, P.; Cazals-Hatem, D.; Valla, D.C.; Vilgrain, V. Acute extrahepatic infectious or inflammatory diseases are a cause of transient mosaic pattern on CT and MR imaging related to sinusoidal dilatation of the liver. Eur. Radiol.,  2016, 26(9), 3094-3101.
 [http://dx.doi.org/10.1007/s00330-015-4124-2] [PMID: 26615556]

[13]
Mancuso, A. Agreed diagnostic criteria needed for Budd-Chiari syndrome. Br. J. Radiol.,  2020, 93(1110)20200259
 [http://dx.doi.org/10.1259/bjr.20200259] [PMID: 32310674]

[14]
Nawel, A.; Nabil, D. Hepatocellular carcinoma in Budd-Chiari syndrome. In: Budd-Chiari Syndrome; Qi, X., Ed.; Springer Nature: Singapore, 2020, pp. 113-129.

[15]
Van Wettere, M.; Purcell, Y.; Bruno, O.; Payancé, A.; Plessier, A.; Rautou, P.E.; Cazals-Hatem, D.; Valla, D.; Vilgrain, V.; Ronot, M. Low specificity of washout to diagnose hepatocellular carcinoma in nodules showing arterial hyperenhancement in patients with Budd-Chiari syndrome. J. Hepatol.,  2019, 70(6), 1123-1132.
 [http://dx.doi.org/10.1016/j.jhep.2019.01.009] [PMID: 30654065]

[16]
Mancuso, A. Management of hepatocellular carcinoma: Enlightening the gray zones. World J. Hepatol.,  2013, 5(6), 302-310.
 [http://dx.doi.org/10.4254/wjh.v5.i6.302] [PMID: 23805354]

[17]
Dang, X.; Li, L.; Li, S.; Wang, Y.; Li, H.; Xu, S.; Xu, P. Studies on Budd-chiari syndrome complicated with hepatocellular carcinoma: most patients without inferior vena cava obstruction. Int. J. Clin. Exp. Med.,  2015, 8(6), 9071-9078.
 [PMID: 26309561]

[18]
Paul, S.B. Shalimar; Sreenivas, V.; Gamanagatti, S.R.; Sharma, H.; Dhamija, E.; Acharya, S.K. Incidence and risk factors of hepatocellular carcinoma in patients with hepatic venous outflow tract obstruction. Aliment. Pharmacol. Ther.,  2015, 41(10), 961-971.
 [http://dx.doi.org/10.1111/apt.13173] [PMID: 25809735]

[19]
Liu, F.Y.; Wang, M.Q.; Duan, F.; Fan, Q.S.; Song, P.; Wang, Y. Hepatocellular carcinoma associated with Budd-Chiari syndrome: imaging features and transcatheter arterial chemoembolization. BMC Gastroenterol.,  2013, 13, 105.
 [http://dx.doi.org/10.1186/1471-230X-13-105] [PMID: 23800233]

[20]
Park, H.; Yoon, J.Y.; Park, K.H.; Kim, D.Y.; Ahn, S.H.; Han, K.H.; Chon, C.Y.; Park, J.Y. Hepatocellular carcinoma in Budd-Chiari syndrome: a single center experience with long-term follow-up in South Korea. World J. Gastroenterol.,  2012, 18(16), 1946-1952.
 [http://dx.doi.org/10.3748/wjg.v18.i16.1946] [PMID: 22563176]

[21]
Gwon, D.I.I.; Ko, G.Y.; Yoon, H.K.; Sung, K.B.; Kim, J.H.; Lee, S.S.; Lee, J.M.; Ohm, J.Y.; Shin, J.H.; Song, H.Y. Hepatocellular carcinoma associated with membranous obstruction of the inferior vena cava: incidence, characteristics, and risk factors and clinical efficacy of TACE. Radiology,  2010, 254(2), 617-626.
 [http://dx.doi.org/10.1148/radiol.09090738] [PMID: 20093533]

[22]
Moucari, R.; Rautou, P.E.; Cazals-Hatem, D.; Geara, A.; Bureau, C.; Consigny, Y.; Francoz, C.; Denninger, M.H.; Vilgrain, V.; Belghiti, J.; Durand, F.; Valla, D.; Plessier, A. Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and risk factors. Gut,  2008, 57(6), 828-835.
 [http://dx.doi.org/10.1136/gut.2007.139477] [PMID: 18218675]

[23]
Mancuso, A. An update on the management of Budd-Chiari syndrome: the issues of timing and choice of treatment. Eur. J. Gastroenterol. Hepatol.,  2015, 27(3), 200-203.
 [http://dx.doi.org/10.1097/MEG.0000000000000282] [PMID: 25590783]

[24]
Seijo, S.; Plessier, A.; Hoekstra, J.; Dell’era, A.; Mandair, D.; Rifai, K.; Trebicka, J.; Morard, I.; Lasser, L.; Abraldes, J.G.; Darwish Murad, S.; Heller, J.; Hadengue, A.; Primignani, M.; Elias, E.; Janssen, H.L.; Valla, D.C.; Garcia-Pagan, J.C. European network for vascular disorders of the liver. Good long-term outcome of Budd-Chiari syndrome with a step-wise management. Hepatology,  2013, 57(5), 1962-1968.
 [http://dx.doi.org/10.1002/hep.26306] [PMID: 23389867]

[25]
Rautou, P.E.; Douarin, L.; Denninger, M.H.; Escolano, S.; Lebrec, D.; Moreau, R.; Vidaud, M.; Itzykson, R.; Moucari, R.; Bezeaud, A.; Valla, D.; Plessier, A. Bleeding in patients with Budd-Chiari syndrome. J. Hepatol.,  2011, 54(1), 56-63.
 [http://dx.doi.org/10.1016/j.jhep.2010.06.019] [PMID: 20889223]

[26]
Wanless, I.R.; Wong, F.; Blendis, L.M.; Greig, P.; Heathcote, E.J.; Levy, G. Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension. Hepatology,  1995, 21(5), 1238-1247.
 [PMID: 7737629]

[27]
Pan, S.; Kleppe, L.S.; Witt, T.A.; Mueske, C.S.; Simari, R.D. The effect of vascular smooth muscle cell-targeted expression of tissue factor pathway inhibitor in a murine model of arterial thrombosis. Thromb. Haemost.,  2004, 92(3), 495-502.
 [http://dx.doi.org/10.1160/TH04-01-0006] [PMID: 15351845]

[28]
Mancuso, A. Cirrhosis development probably arises from chronic micro-vascular ischemia. Med. Hypotheses,  2014, 82(2), 244.
 [http://dx.doi.org/10.1016/j.mehy.2013.11.044] [PMID: 24389105]

[29]
Mancuso, A. The ischemic liver cirrhosis theory and its clinical implications. Med. Hypotheses,  2016, 94, 4-6.
 [http://dx.doi.org/10.1016/j.mehy.2016.06.008] [PMID: 27515188]

[30]
Simonetto, D.H.; Yang, H.Y.; Yin, M. Chronic passive venous congestion drives hepatic fibro-genesis via sinusoidal thrombosis and mechanical forces. Hepatology,  2015, 61, 649-659.
 [http://dx.doi.org/10.1002/hep.27387]

[31]
Mancuso, A. Letter: Target of TIPSS for Budd-Chiari syndrome should be avoiding liver transplant. Aliment. Pharmacol. Ther.,  2014, 39(11), 1342.
 [http://dx.doi.org/10.1111/apt.12738] [PMID: 24803257]

[32]
Mancuso, A. TIPS for Budd-Chiari syndrome: time to anticipate treatment. Liver Int.,  2014, 34(7)e325
 [http://dx.doi.org/10.1111/liv.12544] [PMID: 24650135]

[33]
Mancuso, A. Budd-chiari syndrome management: Timing of treatment is an open issue. Hepatology,  2014, 59(3), 1213.
 [http://dx.doi.org/10.1002/hep.26619] [PMID: 23857382]

[34]
Mancuso, A. Limits of evidence based medicine for rare diseases: The case of Budd-chiari syndrome. Dig. Liver Dis.,  2016, 48(6), 689.
 [http://dx.doi.org/10.1016/j.dld.2016.02.025] [PMID: 27005858]

[35]
Plessier, A.; Sibert, A.; Consigny, Y.; Hakime, A.; Zappa, M.; Denninger, M.H.; Condat, B.; Farges, O.; Chagneau, C.; de Ledinghen, V.; Francoz, C.; Sauvanet, A.; Vilgrain, V.; Belghiti, J.; Durand, F.; Valla, D. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology,  2006, 44(5), 1308-1316.
 [http://dx.doi.org/10.1002/hep.21354] [PMID: 17058215]

[36]
De Gottardi, A.; Trebicka, J.; Klinger, C.; Plessier, A.; Seijo, S.; Terziroli, B.; Magenta, L.; Semela, D.; Buscarini, E.; Langlet, P.; Görtzen, J.; Puente, A.; Müllhaupt, B.; Navascuès, C.; Nery, F.; Deltenre, P.; Turon, F.; Engelmann, C.; Arya, R.; Caca, K.; Peck-Radosavljevic, M.; Leebeek, F.W.G.; Valla, D.; Garcia-Pagan, J.C.; Investigators, V.A.L.D.I.G. VALDIG Investigators. Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis. Liver Int.,  2017, 37(5), 694-699.
 [http://dx.doi.org/10.1111/liv.13285] [PMID: 27778440]

[37]
Bilbao, J.I.; Pueyo, J.C.; Longo, J.M.; Arias, M.; Herrero, J.I.; Benito, A.; Barettino, M.D.; Perotti, J.P.; Pardo, F. Interventional therapeutic techniques in Budd-Chiari syndrome. Cardiovasc. Intervent. Radiol.,  1997, 20(2), 112-119.
 [http://dx.doi.org/10.1007/s002709900117] [PMID: 9030501]

[38]
Fisher, N.C.; McCafferty, I.; Dolapci, M.; Wali, M.; Buckels, J.A.; Olliff, S.P.; Elias, E. Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting. Gut,  1999, 44(4), 568-574.
 [http://dx.doi.org/10.1136/gut.44.4.568] [PMID: 10075967]

[39]
Eapen, C.E.; Velissaris, D.; Heydtmann, M.; Gunson, B.; Olliff, S.; Elias, E. Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome. Gut,  2006, 55(6), 878-884.
 [http://dx.doi.org/10.1136/gut.2005.071423] [PMID: 16174658]

[40]
Wang, Q.; Li, K.; He, C.; Yuan, X.; Luo, B.; Qi, X.; Guo, W.; Bai, W.; Yu, T.; Fan, J.; Wang, Z.; Yuan, J.; Li, X.; Zhu, Y.; Han, N.; Niu, J.; Lv, Y.; Liu, L.; Li, J.; Tang, S.; Guo, S.; Wang, E.; Xia, D.; Wang, Z.; Cai, H.; Wang, J.; Yin, Z.; Xia, J.; Fan, D.; Han, G. Angioplasty with versus without routine stent placement for Budd-Chiari syndrome: a randomised controlled trial. Lancet Gastroenterol. Hepatol.,  2019, 4(9), 686-697.
 [http://dx.doi.org/10.1016/S2468-1253(19)30177-3] [PMID: 31279647]

[41]
Perelló, A.; García-Pagán, J.C.; Gilabert, R.; Suárez, Y.; Moitinho, E.; Cervantes, F.; Reverter, J.C.; Escorsell, A.; Bosch, J.; Rodés, J. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. Hepatology,  2002, 35(1), 132-139.
 [http://dx.doi.org/10.1053/jhep.2002.30274] [PMID: 11786969]

[42]
Mancuso, A.; Fung, K.; Mela, M.; Tibballs, J.; Watkinson, A.; Burroughs, A.K.; Patch, D. TIPS for acute and chronic Budd-Chiari syndrome: a single-centre experience. J. Hepatol.,  2003, 38(6), 751-754.
 [http://dx.doi.org/10.1016/S0168-8278(03)00118-1] [PMID: 12763367]

[43]
Rössle, M.; Olschewski, M.; Siegerstetter, V.; Berger, E.; Kurz, K.; Grandt, D. The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt. Surgery,  2004, 135(4), 394-403.
 [http://dx.doi.org/10.1016/j.surg.2003.09.005] [PMID: 15041963]

[44]
Mancuso, A.; Watkinson, A.; Tibballs, J.; Patch, D.; Burroughs, A.K. Budd-Chiari syndrome with portal, splenic, and superior mesenteric vein thrombosis treated with TIPS: who dares wins. Gut,  2003, 52(3), 438.
 [http://dx.doi.org/10.1136/gut.52.3.438] [PMID: 12584231]

[45]
Darwish Murad, S.; Valla, D.C.; de Groen, P.C.; Zeitoun, G.; Haagsma, E.B.; Kuipers, E.J.; Janssen, H.L. Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis. Am. J. Gastroenterol.,  2006, 101(1), 83-90.
 [http://dx.doi.org/10.1111/j.1572-0241.2006.00353.x] [PMID: 16405538]

[46]
Garcia-Pagán, J.C.; Heydtmann, M.; Raffa, S.; Plessier, A.; Murad, S.; Fabris, F.; Vizzini, G.; Gonzales Abraldes, J.; Olliff, S.; Nicolini, A.; Luca, A.; Primignani, M.; Janssen, H.L.; Valla, D.; Elias, E.; Bosch, J. Budd-Chiari Syndrome-Transjugular Intrahepatic Portosystemic Shunt Group. TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients. Gastroenterology,  2008, 135(3), 808-815.
 [http://dx.doi.org/10.1053/j.gastro.2008.05.051] [PMID: 18621047]

[47]
Qi, X.; Guo, W.; He, C.; Zhang, W.; Wu, F.; Yin, Z.; Bai, M.; Niu, J.; Yang, Z.; Fan, D.; Han, G. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: techniques, indications and results on 51 Chinese patients from a single centre. Liver Int.,  2014, 34(8), 1164-1175.
 [http://dx.doi.org/10.1111/liv.12355] [PMID: 24256572]

[48]
Tripathi, D.; Macnicholas, R.; Kothari, C.; Sunderraj, L.; Al-Hilou, H.; Rangarajan, B.; Chen, F.; Mangat, K.; Elias, E.; Olliff, S. Good clinical outcomes following transjugular intrahepatic portosystemic stent-shunts in Budd-Chiari syndrome. Aliment. Pharmacol. Ther.,  2014, 39(8), 864-872.
 [http://dx.doi.org/10.1111/apt.12668] [PMID: 24611957]

[49]
Ringe, B.; Lang, H.; Oldhafer, K.J.; Gebel, M.; Flemming, P.; Georgii, A.; Borst, H.G.; Pichlmayr, R. Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients. Hepatology,  1995, 21(5), 1337-1344.
 [http://dx.doi.org/10.1002/hep.1840210518] [PMID: 7737640]

[50]
Hemming, A.W.; Langer, B.; Greig, P.; Taylor, B.R.; Adams, R.; Heathcote, E.J. Treatment of Budd-Chiari syndrome with portosystemic shunt or liver transplantation. Am. J. Surg.,  1996, 171(1), 176-180.
 [http://dx.doi.org/10.1016/S0002-9610(99)80095-6] [PMID: 8554136]

[51]
Orloff, M.J.; Isenberg, J.I.; Wheeler, H.O.; Daily, P.O.; Girard, B. Budd-Chiari syndrome revisited: 38 years’ experience with surgical portal decompression. J. Gastrointest. Surg.,  2012, 16(2), 286-300.
 [http://dx.doi.org/10.1007/s11605-011-1738-9] [PMID: 22065317]

[52]
Zhang, Y.; Zhao, H.; Yan, D.; Xue, H.; Lau, W.Y. Superior mesenteric vein-caval-right atrium Y shunt for treatment of Budd-Chiari syndrome with obstruction to the inferior vena cava and the hepatic veins--a study of 62 patients. J. Surg. Res.,  2011, 169(1), e93-e99.
 [http://dx.doi.org/10.1016/j.jss.2011.02.030] [PMID: 21529832]

[53]
Mancuso, A.; Martinelli, L.; De Carlis, L.; Rampoldi, A.G.; Magenta, G.; Cannata, A.; Belli, L.S. A caval homograft for Budd-Chiari syndrome due to inferior vena cava obstruction. World J. Hepatol.,  2013, 5(5), 292-295.
 [http://dx.doi.org/10.4254/wjh.v5.i5.292] [PMID: 23717741]

[54]
Srinivas, B.C.; Dattatreya, P.V.; Srinivasa, K.H.; Prabhavathi, C.N.; Manjunath, C.N. Inferior vena cava obstruction: long-term results of endovascular management. Indian Heart J.,  2012, 64(2), 162-169.
 [http://dx.doi.org/10.1016/S0019-4832(12)60054-6] [PMID: 22572493]

[55]
Li, Q.; Zhang, T.; Wang, D.; Li, W.; Zhang, X.; Zhang, X. Radical surgical treatment of Budd-Chiari syndrome through entire exposure of hepatic inferior vena cava. J. Vasc. Surg. Venous Lymphat. Disord.,  2019, 7(1), 74-81.
 [http://dx.doi.org/10.1016/j.jvsv.2018.02.007] [PMID: 30341019]

[56]
Halff, G.; Todo, S.; Tzakis, A.G.; Gordon, R.D.; Starzl, T.E. Liver transplantation for the Budd-Chiari syndrome. Ann. Surg.,  1990, 211(1), 43-49.
 [http://dx.doi.org/10.1097/00000658-199001000-00007] [PMID: 2294842]

[57]
Rao, A.R.; Chui, A.K.; Gurkhan, A.; Shi, L.W.; Al-Harbi, I.; Waugh, R.; Verran, D.J.; McCaughan, G.W.; Koorey, D.; Sheil, A.G. Orthotopic liver transplantation for treatment of patients with Budd-Chiari syndrome: a Singe-center experience. Transplant. Proc.,  2000, 32(7), 2206-2207.
 [http://dx.doi.org/10.1016/S0041-1345(00)01636-5] [PMID: 11120134]

[58]
Ulrich, F.; Steinmüller, T.; Lang, M.; Settmacher, U.; Müller, A.R.; Jonas, S.; Tullius, S.G.; Neuhaus, P. Liver transplantation in patients with advanced Budd-Chiari syndrome. Transplant. Proc.,  2002, 34(6), 2278.
 [http://dx.doi.org/10.1016/S0041-1345(02)03234-7] [PMID: 12270397]

[59]
Srinivasan, P.; Rela, M.; Prachalias, A.; Muiesan, P.; Portmann, B.; Mufti, G.J.; Pagliuca, A.; O’Grady, J.; Heaton, N. Liver transplantation for Budd-Chiari syndrome. Transplantation,  2002, 73(6), 973-977.
 [http://dx.doi.org/10.1097/00007890-200203270-00026] [PMID: 11923703]

[60]
Mentha, G.; Giostra, E.; Majno, P.E.; Bechstein, W.O.; Neuhaus, P.; O’Grady, J.; Praseedom, R.K.; Burroughs, A.K.; Le Treut, Y.P.; Kirkegaard, P.; Rogiers, X.; Ericzon, B.G.; Hockerstedt, K.; Adam, R.; Klempnauer, J. Liver transplantation for Budd-Chiari syndrome: A European study on 248 patients from 51 centres. J. Hepatol.,  2006, 44(3), 520-528.
 [http://dx.doi.org/10.1016/j.jhep.2005.12.002] [PMID: 16427719]

[61]
Segev, D.L.; Nguyen, G.C.; Locke, J.E.; Simpkins, C.E.; Montgomery, R.A.; Maley, W.R.; Thuluvath, P.J. Twenty years of liver transplantation for Budd-Chiari syndrome: a national registry analysis. Liver Transpl.,  2007, 13(9), 1285-1294.
 [http://dx.doi.org/10.1002/lt.21220] [PMID: 17763380]

[62]
Potthoff, A.; Attia, D.; Pischke, S.; Mederacke, I.; Beutel, G.; Rifai, K.; Deterding, K.; Heiringhoff, K.; Klempnauer, J.; Strassburg, C.P.; Manns, M.P.; Bahr, M.J. Long-term outcome of liver transplant patients with Budd-Chiari syndrome secondary to myeloproliferative neoplasms. Liver Int.,  2015, 35(8), 2042-2049.
 [http://dx.doi.org/10.1111/liv.12816] [PMID: 25736096]

[63]
Mancuso, A. Time to resize the role of liver transplant for Budd-Chiari syndrome. Liver Int.,  2015, 35(10), 2339.
 [http://dx.doi.org/10.1111/liv.12828] [PMID: 25790310]

[64]
Alukal, J.J.; Zhang, T.; Thuluvath, P.J. Outcomes of status 1 liver transplantation for Budd-Chiari Syndrome with fulminant hepatic failure. Am. J. Transplant.,  IN PRESS
 [PMID: 33236517]

[65]
Choi, G.S.; Park, J.B.; Jung, G.O.; Chun, J.M.; Kim, J.M.; Moon, J.I.; Kwon, C.H.; Kim, S.J.; Joh, J.W.; Lee, S.K. Living donor liver transplantation in Budd-Chiari syndrome: a single-center experience. Transplant. Proc.,  2010, 42(3), 839-842.
 [http://dx.doi.org/10.1016/j.transproceed.2010.02.045] [PMID: 20430186]

[66]
Yoon, Y.I.; Lee, S.G.; Moon, D.B.; Ahn, C.S.; Hwang, S.; Kim, K.H.; Ha, T.Y.; Song, G.W.; Jung, D.H.; Park, G.C.; Kim, D.S.; Choo, S.J. Surgical techniques and long-term outcomes of living-donor liver transplantation with inferior vena cava replacement using atriocaval synthetic interposition graft for Budd-Chiari syndrome. Ann. Surg.,  2019, 269(4), e43-e45.
 [http://dx.doi.org/10.1097/SLA.0000000000002847] [PMID: 30080720]

[67]
Darwish Murad, S.; Plessier, A.; Hernandez-Guerra, M.; Fabris, F.; Eapen, C.E.; Bahr, M.J.; Trebicka, J.; Morard, I.; Lasser, L.; Heller, J.; Hadengue, A.; Langlet, P.; Miranda, H.; Primignani, M.; Elias, E.; Leebeek, F.W.; Rosendaal, F.R.; Garcia-Pagan, J.C.; Valla, D.C.; Janssen, H.L. EN-Vie (European Network for Vascular Disorders of the Liver). Etiology, management, and outcome of the Budd-Chiari syndrome. Ann. Intern. Med.,  2009, 151(3), 167-175.
 [http://dx.doi.org/10.7326/0003-4819-151-3-200908040-00004] [PMID: 19652186]

[68]
Qi, X.; Ren, W.; Wang, Y.; Guo, X.; Fan, D. Survival and prognostic indicators of Budd-Chiari syndrome: a systematic review of 79 studies. Expert Rev. Gastroenterol. Hepatol.,  2015, 9(6), 865-875.
 [http://dx.doi.org/10.1586/17474124.2015.1024224] [PMID: 25754880]

[69]
Mancuso, A. Management of Budd-Chiari syndrome in children: same debated issues as in adults. Eur. J. Gastroenterol. Hepatol.,  2015, 27(1), 107-108.
 [http://dx.doi.org/10.1097/MEG.0000000000000232] [PMID: 25426986]

[70]
Mancuso, A. Outcome of Budd-Chiari syndrome in Behçetys syndrome. Semin. Arthritis Rheum.,  2015, 45(1), e1.
 [http://dx.doi.org/10.1016/j.semarthrit.2015.04.004] [PMID: 25953713]

[71]
He, F.; Zhao, H.; Dai, S.; Wu, Y.; Wang, L.; Huang, H.; Yue, Z.; Fan, Z.; Dong, X.; Liu, F. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome with diffuse occlusion of hepatic veins. Sci. Rep.,  2016, 6, 36380.
 [http://dx.doi.org/10.1038/srep36380] [PMID: 27805025]

[72]
Rosenqvist, K.; Sheikhi, R.; Eriksson, L.G.; Rajani, R.; Rorsman, F.; Sangfelt, P.; Nyman, R. Endovascular treatment of symptomatic Budd-Chiari syndrome - in favour of early transjugular intrahepatic portosystemic shunt. Eur. J. Gastroenterol. Hepatol.,  2016, 28(6), 656-660.
 [http://dx.doi.org/10.1097/MEG.0000000000000621] [PMID: 26958788]

[73]
Wang, H.W.; Shi, H.N.; Cheng, J.; Xie, F.; Luo, Y.K.; Tang, J. Real-time shear wave elastography (SWE) assessment of short- and long-term treatment outcome in Budd-Chiari syndrome: A pilot study. PLoS One,  2018, 13(5)e0197550
 [http://dx.doi.org/10.1371/journal.pone.0197550] [PMID: 29847588]

[74]
Su, L.; Hu, L.; Liang, P.; Wu, Y.; Sun, Q.; Gao, J. Clinical efficacy of spectral computed tomography for evaluating liver function in patients with Budd-Chiari syndrome. Acad. Radiol.,  2019, 26(4), 461-466.
 [http://dx.doi.org/10.1016/j.acra.2018.05.003] [PMID: 30098862]

[75]
Mancuso, A. Controversies in the management of Budd-chiari syndrome. In: Budd-Chiari Syndrome; Qi, X., Ed.; Springer Nature: Singapore, 2020, pp. 245-252.
 [http://dx.doi.org/10.1007/978-981-32-9232-1_19]

[76]
Mancuso, A.; Amata, M.; Politi, F.; Mitra, M.; Marsala, M.G.L.; Maringhini, A. Controversies in Budd-Chiari syndrome management: potential role of liver stiffness. Am. J. Gastroenterol.,  2020, 115(6), 952-953.
 [http://dx.doi.org/10.14309/ajg.0000000000000586] [PMID: 32287138]

[77]
Ho, H.; Qiu, C. Hemodynamic aspects of the Budd-Chiari syndrome of the liver: A computational model study. Med. Eng. Phys.,  2019, 69 134-139. Hemodynamic aspects of the Budd-Chiari syndrome of the liver: A computational model study.
 [http://dx.doi.org/10.1016/j.medengphy.2019.04.010] [PMID: 31078370]

[78]
 Mancuso, A. Med. Eng. Phys., 2019, 9, 71. https://www.ncbi.nlm.nih.gov/pubmed/31324448\h
Rights & Permissions Print Cite
Article Metrics
4
Journal Information
For Authors
For Editors
For Reviewers
Explore Articles
Open Access
Open Access Articles
For Visitors
DOI https://dx.doi.org/10.2174/2666290601666210406162525	Print ISSN 2666-2906
Publisher Name Bentham Science Publisher	Online ISSN 2666-2914
The International Journal of Gastroenterology and Hepatology Diseases

Focusing the Controversies in Budd-Chiari Syndrome Management

Abstract Play Pause

Related Books

Related Articles

Abstract
